Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.

This study tests an experimental drug called TQH2722 for adults with moderate to severe eczema (atopic dermatitis). About 500 people will receive either the drug or a placebo to see if it safely reduces skin redness, itching, and rash. The goal is to improve quality of life by co…

This study tests an experimental drug called TQC2731 in 258 adults aged 40-80 with moderate to severe COPD. Participants receive either the drug or a placebo to see if it reduces the number of serious flare-ups over 24 weeks and improves breathing. The goal is to better control t…